Bayer AG - Leverkusen, Germany-based pharmaceutical and biotechnology company - Signs an agreement with agricultural biotechnology company AlphaBio Control Ltd to secure exclusive rights to market a new biological insecticide. The as-yet-unnamed product, expected for initial launch in 2028, will be the first of its kind available for arable crops.

Ralf Glaubitz, head of global asset management for Seed Growth & Biologics at Bayer’s Crop Science division, says: "With increasingly strong demand from farmers and changing consumer preferences, we see major growth potential for biological crop protections like this one. We're working to outgrow the market and achieve more than EUR1.5 billion in biological sales by 2035. That’s only going to happen if we innovate to solve the challenges that farmers face in all fields."

Marta Ruiz, general manager for AlphaBio Control, comments: "We are delighted to license Bayer exclusive rights to our latest bioinsecticide which will significantly improve the choices available to arable farmers wishing to reduce the environmental impact of food production."

Current stock price: EUR27.35

12-month change: down 55%

By Hugh Cameron, Alliance News reporter

Comments and questions to newsroom@alliancenews.com